Stay updated with breaking news from B Cell Select. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, and welcome to IPA's Earnings Call for the Third Quarter Fiscal Year 2023. I am Regina, and I will be your host for today's call.
Announced Strategic Partnership with Mila to Expand AI Capabilities and Functionality of Antibody Development Platform Advanced Lead Candidates for COVID-19 PolyTope™ Cocktail Therapy, Preclinical Trials Scheduled to Launch in January 2021 VICTORIA, BC, Dec. 21, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) today announced financial results for the second quarter of its 2021 fiscal year ended October 31, 2020. Q2 Fiscal 2021 Financial Highlights: Revenue was $4.8 million for the quarter ended October 31, 2020, an increase of $1.6 million,...